Company Name Nellix
Mailing Address 2465-B Faber Place Palo Alto, CA 94303
Company Description Nellix has developed a revolutionary, percutaneously deliverable endograft for the treatment of Abdominal Aortic Aneurysms and Thoracic Aortic Aneurysms. This aortic endograft device and treatment fills the aneurysm, providing a highly stable and durable seal. The novel technology enables treatment of all aortic aneurysms and provides a distinct advantage over current therapies.
M&A Terms Endologix has acquired venture-backed medical device company Nellix Endovascular for $15 million in stock, plus additional milestone-based stock payments totaling as much as $39 million. As part of the acquisition, Nellix’s majority investor, Essex Woodlands Health Ventures, will also invest $15 million in the newly combined company.